SPY is an exchange-traded fund (ETF) that aims to replicate the performance of the S&P 500 Index. The S&P 500 Index includes 500 of the largest publicly traded companies in the United States, representing a broad cross-section of the U.S. economy.
Metrics and analysis →OGN
Organon & Co. is a global healthcare company that focuses on women’s health, biosimilars, and other established medicines.
- Open
- 13.61
- High
- 13.91
- Low
- 13.61
- Prev close
- 13.91
- Volume
- 3M
- Avg vol 10
- 3M
Today · Market closed · opens Mon 9:30 AM
OGN chart
Scroll or pinch to zoom, drag to pan, or use the buttons on the chart. About the price history
Technical analysis
Daily bars · last bar Nov 20, 2026 · close 13.89
Leaning buy. 8 of 18 signals point up against 2 down, carried by momentum and trend. Volatility is mostly neutral. Volume is mostly neutral. MFI sits in overbought territory. Trend strength is very strong (ADX 41).
Trend
Momentum
Volatility
Volume
Leaning buy. The close is above 18 of 24 averages and below 6. Price is mixed around the short-term averages (5 to 20) and above the long-term ones (50 to 200). SMA 50 is above SMA 200 (13.78 vs 11.89).
| Period | SMA | EMA | WMA | WEMA |
|---|---|---|---|---|
| 5 | 13.90 | 13.90 | 13.90 | 13.89 |
| 10 | 13.89 | 13.89 | 13.90 | 13.86 |
| 20 | 13.85 | 13.86 | 13.88 | 13.81 |
| 50 | 13.78 | 13.78 | 13.82 | 13.41 |
| 100 | 13.70 | 13.41 | 13.76 | 12.40 |
| 200 | 11.89 | 12.43 | 13.20 | 11.09 |
Green: the close is above that average. Red: below it.
From the bar before the last one. Nearest classic support is S1 at 13.89. Nearest resistance is the pivot at 13.92.
| Level | Classic | Fibonacci | Camarilla | Floor | Woodie | DeMark |
|---|---|---|---|---|---|---|
| R3 | 14.00 | 13.96 | 13.92 | 13.97 | 13.95 | — |
| R2 | 13.96 | 13.94 | 13.92 | 13.96 | 13.95 | — |
| R1 | 13.93 | 13.93 | 13.91 | 13.93 | 13.91 | 13.93 |
| Pivot | 13.92 | 13.92 | 13.92 | 13.92 | 13.91 | 13.91 |
| S1 | 13.89 | 13.90 | 13.91 | 13.89 | 13.87 | 13.89 |
| S2 | 13.88 | 13.89 | 13.90 | 13.88 | 13.87 | — |
| S3 | 13.84 | 13.88 | 13.90 | 13.85 | 13.83 | — |
Patterns that formed on the last 5 bars, newest first.
A doji with long shadows both ways.
Neither side won the bar. On its own it says little; after a strong move it warns the move is tiring.
A long candle with no shadow at the close: it closed at its high (bullish) or its low (bearish).
Buyers held control into the close.
A small body with shadows longer than the body on both sides.
Neither side won the bar. On its own it says little; after a strong move it warns the move is tiring.
How candlestick references usually rate the pattern. It is not a success rate measured on this ticker. About candle patterns
| Date | Open | High | Low | Close | Volume | Change |
|---|---|---|---|---|---|---|
| Nov 20, 2026 | 13.89 | 13.91 | 13.89 | 13.89 | 4M | 0.00 |
| Nov 19, 2026 | 13.92 | 13.94 | 13.90 | 13.91 | 3M | −0.01 |
| Nov 18, 2026 | 13.89 | 13.92 | 13.88 | 13.92 | 4M | +0.03 |
| Nov 17, 2026 | 13.90 | 13.91 | 13.89 | 13.90 | 4M | 0.00 |
| Nov 16, 2026 | 13.88 | 13.91 | 13.88 | 13.90 | 4M | +0.02 |
| Nov 13, 2026 | 13.90 | 13.90 | 13.88 | 13.90 | 4M | 0.00 |
| Nov 12, 2026 | 13.87 | 13.90 | 13.87 | 13.90 | 3M | +0.03 |
| Nov 11, 2026 | 13.89 | 13.89 | 13.86 | 13.89 | 2M | 0.00 |
| Nov 10, 2026 | 13.83 | 13.89 | 13.83 | 13.89 | 2M | +0.06 |
| Nov 9, 2026 | 13.87 | 13.88 | 13.82 | 13.85 | 3M | −0.02 |
| Nov 6, 2026 | 13.80 | 13.87 | 13.78 | 13.87 | 4M | +0.07 |
| Nov 5, 2026 | 13.86 | 13.86 | 13.79 | 13.79 | 4M | −0.07 |
| Nov 4, 2026 | 13.83 | 13.88 | 13.83 | 13.83 | 3M | 0.00 |
| Nov 3, 2026 | 13.83 | 13.85 | 13.83 | 13.85 | 4M | +0.02 |
| Nov 2, 2026 | 13.85 | 13.85 | 13.82 | 13.82 | 2M | −0.03 |
| Oct 30, 2026 | 13.83 | 13.84 | 13.81 | 13.84 | 2M | +0.01 |
| Oct 29, 2026 | 13.76 | 13.83 | 13.76 | 13.81 | 3M | +0.05 |
| Oct 28, 2026 | 13.75 | 13.78 | 13.75 | 13.78 | 3M | +0.03 |
| Oct 27, 2026 | 13.74 | 13.78 | 13.74 | 13.75 | 2M | +0.01 |
| Oct 26, 2026 | 13.75 | 13.76 | 13.74 | 13.74 | 2M | −0.01 |
| Oct 23, 2026 | 13.74 | 13.76 | 13.74 | 13.75 | 1M | +0.01 |
| Oct 22, 2026 | 13.75 | 13.76 | 13.74 | 13.75 | 3M | 0.00 |
| Oct 21, 2026 | 13.75 | 13.77 | 13.74 | 13.75 | 3M | 0.00 |
| Oct 20, 2026 | 13.75 | 13.80 | 13.74 | 13.76 | 3M | +0.01 |
| Oct 19, 2026 | 13.77 | 13.77 | 13.72 | 13.75 | 3M | −0.02 |
| Oct 16, 2026 | 13.77 | 13.78 | 13.74 | 13.76 | 3M | −0.01 |
| Oct 15, 2026 | 13.75 | 13.77 | 13.75 | 13.76 | 2M | +0.01 |
| Oct 14, 2026 | 13.77 | 13.77 | 13.74 | 13.74 | 2M | −0.03 |
| Oct 13, 2026 | 13.77 | 13.79 | 13.76 | 13.77 | 3M | 0.00 |
| Oct 12, 2026 | 13.80 | 13.80 | 13.76 | 13.77 | 932K | −0.03 |
Performance
Daily returns for Jan 1, 2026 – Nov 22, 2026 (YTD). About the returns · About the risk figures
1 month return
1.02%
Change in value over the past month.
3 month return
1.02%
Change in value over the last three months.
Max drawdown
41.60%
Largest fall from a peak to the low that followed.
Standard deviation
59.93%
How far daily returns stray from their average, annualised.
Sharpe ratio
1.49
Return above the risk-free rate per unit of volatility.
Calmar ratio
2.15
Annualised return against the maximum drawdown.
OGN summary
Loading summary…
OGN, answered
What challenges does Organon face in the market?
Challenges include competition in the pharmaceutical industry and the need to continuously innovate and adapt.
What is Organon’s strategy for growth?
Organon aims to grow through expanding its portfolio in women’s health and entering new markets.
How can investors stay updated on Organon’s performance?
Investors can check the investor relations section of Organon’s website for financial reports and updates.
What are the main therapeutic areas of Organon?
Organon focuses on women’s health, fertility, contraception, and various chronic conditions.
What recent developments have occurred at Organon?
Recent developments include product launches and partnerships aimed at expanding their healthcare offerings.
Is Organon publicly traded?
Yes, Organon is publicly traded on the New York Stock Exchange under the ticker symbol OGN.
What is Organon’s mission?
Organon’s mission is to deliver impactful medicines to improve the lives of women and their families.
How does Organon approach innovation?
Organon emphasizes research and development to innovate within women’s health and other established medicines.
Who are Organon’s major customers?
Organon’s major customers include healthcare providers, hospitals, and pharmacies worldwide.
Where is Organon headquartered?
Organon is headquartered in Jersey City, New Jersey.
Top market assets
Discover our curated selection of top-performing exchange-traded funds (ETFs) that represent a diverse range of investment opportunities.
QQQ is an exchange-traded fund (ETF) that tracks the performance of the Nasdaq-100 Index. This index includes 100 of the largest non-financial companies listed on the Nasdaq Stock Market, primarily focusing on technology and innovation sectors.
Metrics and analysis →DIA is an exchange-traded fund (ETF) that aims to track the performance of the Dow Jones Industrial Average (DJIA). The DJIA is a stock market index consisting of 30 large, publicly traded companies in the United States, representing a broad range of industries.
Metrics and analysis →IWM is an exchange-traded fund (ETF) that seeks to track the performance of the Russell 2000 Index. The Russell 2000 Index measures the performance of the 2,000 smallest stocks in the Russell 3000 Index, representing a broad segment of small-cap U.S. companies.
Metrics and analysis →Maximize Your OGN Trading Now
Experience the future of trading with ohlcx.com. Our advanced system delivers in-depth analysis and insights for OGN, utilizing state-of-the-art technical tools and strategies. Enhance your market performance today and see how we can elevate your trading results!
Disclaimers
The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.
With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.
Prices, charts and every figure derived from them are delayed by at least 15 minutes and are provided for information only; we do not guarantee their accuracy or timeliness.
Securities products are: Not FDIC insured · Not bank guaranteed · May lose value
Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.